Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nuo Therapeutics Inc (AURX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10122
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company’s flagship product, Aurix System, is a biodynamic hematogel designed to harness a patient’s innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has its facilities in Nashville, Tennessee; and Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc (AURX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aldagen Raises Additional US$0.06 Million In Venture Financing 11
Equity Offering 12
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 12
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 13
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 14
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 15
Cytomedix Completes Private Placement Of Shares For US$5 Million 16
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 17
Cytomedix Announces Private Placement Of Shares For US$15 Million 18
Cytomedix Completes Private Placement Of Shares For US$7 Million 19
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 20
Debt Offering 21
Cytomedix Raises USD26 Million in Second Tranche of Private Placement Debt Securities Due 2019 21
Cytomedix Completes Private Placement Of Notes For US$3 Million 22
Acquisition 23
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 23
Nuo Therapeutics Inc – Key Competitors 25
Nuo Therapeutics Inc – Key Employees 26
Nuo Therapeutics Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Legal and Regulatory 28
Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aldagen Raises Additional US$0.06 Million In Venture Financing 11
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 12
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 13
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 14
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 15
Cytomedix Completes Private Placement Of Shares For US$5 Million 16
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 17
Cytomedix Announces Private Placement Of Shares For US$15 Million 18
Cytomedix Completes Private Placement Of Shares For US$7 Million 19
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 20
Cytomedix Raises USD26 Million in Second Tranche of Private Placement Debt Securities Due 2019 21
Cytomedix Completes Private Placement Of Notes For US$3 Million 22
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 23
Nuo Therapeutics Inc, Key Competitors 25
Nuo Therapeutics Inc, Key Employees 26
Nuo Therapeutics Inc, Other Locations 27
Nuo Therapeutics Inc, Subsidiaries 27

List of Figures
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SLM Corp:企業の戦略・SWOT・財務情報
    SLM Corp - Strategy, SWOT and Corporate Finance Report Summary SLM Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Kaken Pharmaceutical Co Ltd (4521):企業の財務・戦略的SWOT分析
    Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dongwon F&B Co., Ltd.:企業の戦略・SWOT・財務情報
    Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Luna Innovations Inc (LUNA)-医療機器分野:企業M&A・提携分析
    Summary Luna Innovations Inc (Luna) is a optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company’s products include fiber optic sensing products, fiber optic test and measurement products, high speed optical products, …
  • Enel Green Power SpA:電力:M&Aディール及び事業提携情報
    Summary Enel Green Power SpA (EGP) a subsidiary of Enel SpA, is an energy company that is involved in developing and operating renewable projects. It generates power from wind, biomass, geothermal, solar, and hydropower sources. The company also has interests in various power plants in under constru …
  • Fujifilm SonoSite Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • Koninklijke Vopak NV (VPK):企業の財務・戦略的SWOT分析
    Koninklijke Vopak NV (VPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cerus Energy Group Ltd (CEA):石油・ガス:M&Aディール及び事業提携情報
    Summary Cerus Energy Group Ltd (Cerus Energy), formerly Petrostar Petroleum Corp is an oil and gas company that produces methanol, DME, and petroleum and natural gas. The company offers deep well disposal, storage and terminalling services, and well management services. Its well management services …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Exxon Mobil Corporation:企業のM&A・事業提携・投資動向
    Exxon Mobil Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exxon Mobil Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • FibroGen Inc (FGEN):企業の財務・戦略的SWOT分析
    FibroGen Inc (FGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Systemair AB:企業の戦略・SWOT・財務情報
    Systemair AB - Strategy, SWOT and Corporate Finance Report Summary Systemair AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Navios Maritime Holdings Inc.:企業のM&A・事業提携・投資動向
    Navios Maritime Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • JA Solar Holdings Co Ltd (JASO):企業の財務・戦略的SWOT分析
    JA Solar Holdings Co Ltd (JASO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Nisshin OilliO Group, Ltd.:企業の戦略・SWOT・財務分析
    The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cenveo Worldwide Ltd:企業の戦略的SWOT分析
    Cenveo Worldwide Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Suzano Papel e Celulose SA (SUZB5):企業の財務・戦略的SWOT分析
    Suzano Papel e Celulose SA (SUZB5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • VTB Bank:戦略・SWOT・企業財務分析
    VTB Bank - Strategy, SWOT and Corporate Finance Report Summary VTB Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Astute Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA is a diagnostic equipment provider. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Bonnier AB:企業の戦略的SWOT分析
    Bonnier AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆